pillbase.ru

Orgalutran

Active substance: Ganirelix

ganirelix

Centralised EU authorisationActive

Marketing holder: Organon N.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 10
  • Fyremadel
    INJECTION, SOLUTION · GANIRELIX ACETATE 250 ug/.5mL
    55566-1010
    Ferring Pharmaceuticals Inc.
  • GANIRELIX ACETATE
    INJECTION, SOLUTION · GANIRELIX ACETATE 250 ug/.5mL
    68083-472
    Gland Pharma Limited
  • Ganirelix Acetate
    INJECTION · GANIRELIX ACETATE 250 ug/.5mL
    0548-5001
    Amphastar Pharmaceuticals, Inc.
  • Ganirelix Acetate
    INJECTION, SOLUTION · GANIRELIX ACETATE 250 ug/.5mL
    78206-138
    Organon LLC
  • Ganirelix Acetate
    INJECTION · GANIRELIX ACETATE 250 ug/.5mL
    70700-327
    Xiromed LLC
All products in this country (10)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2e90-7d87-9ca5-c6d122402abf,01a1208c-329a-7e73-9a30-a45c46e2642c,01a1208c-bb15-7535-b975-9cb0de376579,01a12092-8558-748a-afe4-b137a209e54c,01a12096-f4e6-7d47-b75b-a3f3387c7908;count=10 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/000274
Registration status
Active
ATC code
H01CC01
Sources
  • product · EMA · EMEA/H/C/000274 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/000274 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/000274 · Verified 2026-10-09